uniQure Announces Successful Readministration of Gene Therapy in Non-Human Primates
May 11, 2017 11:01 am UTC| Business
–Effective Transduction Achieved After Readministration of Gene Transfer – –Preclinical Data Presented Today at American Society of Gene Cell Therapy (ASGCT) Annual Meeting in Washington, D.C.– –Investor Analyst...
dynaCERT Collaboration with Northwest Territory Power Corp.
May 11, 2017 11:01 am UTC| Business
TORONTO, May 11, 2017 -- dynaCERT Inc. (TSX-V:DYA)(OTCQB:DYFSF) ("dynaCERT" or the "Company") is pleased to announce the collaboration with the NTPC (Northwest Territory Power Corp. in Yellowknife, NT) in a fuel savings...
dynaCERT Collaboration with Northwest Territory Power Corp.
May 11, 2017 11:01 am UTC| Business
TORONTO, May 11, 2017 -- dynaCERT Inc. (TSX-V:DYA)(OTCQB:DYFSF) ("dynaCERT" or the "Company") is pleased to announce the collaboration with the NTPC (Northwest Territory Power Corp. in Yellowknife, NT) in a fuel savings...
Natus Medical to Host Analyst Day on June 22nd
May 11, 2017 11:01 am UTC| Business
PLEASANTON, Calif., May 11, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will host an analyst day in New York, New York on Thursday, June 22, 2017. The meeting will be held at the...
Natus Medical to Host Analyst Day on June 22nd
May 11, 2017 11:01 am UTC| Business
PLEASANTON, Calif., May 11, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will host an analyst day in New York, New York on Thursday, June 22, 2017. The meeting will be held at the...
Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights
May 11, 2017 11:01 am UTC| Business
MENLO PARK, Calif., May 11, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights
May 11, 2017 11:01 am UTC| Business
MENLO PARK, Calif., May 11, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...